Neurons expressing the dopamine transporter (DAT), essential for dopamine reuptake and homeostasis. [@vaughan1995] DAT is a membrane protein that mediates the high-affinity reuptake of dopamine from the synaptic cleft, playing a critical role in dopaminergic neurotransmission and motor control. [@bannon2001] These neurons are primarily located in the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA), forming the nigrostriatal and mesolimbic pathways respectively. [@gainetdinov2003]
Neurons expressing the dopamine transporter (DAT), essential for dopamine reuptake and homeostasis. [@vaughan1995] DAT is a membrane protein that mediates the high-affinity reuptake of dopamine from the synaptic cleft, playing a critical role in dopaminergic neurotransmission and motor control. [@bannon2001] These neurons are primarily located in the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA), forming the nigrostriatal and mesolimbic pathways respectively. [@gainetdinov2003]
Overview
Mermaid diagram (expand to render)
Molecular Biology
Gene and Protein Structure
The SLC6A3 gene encodes the dopamine transporter, a 620-amino acid protein with 12 transmembrane domains. [@miller1999] DAT belongs to the neurotransmitter sodium symporter (NSS) family and requires sodium and chloride ions for function. [@vaughan1995]
Regulation
Transcriptional: Transcription factors including Nurr1, Pitx3, and FOXA2 regulate DAT expression
Post-translational: Phosphorylation, glycosylation, and ubiquitination affect DAT trafficking and function
Dynamic: DAT surface expression is modulated by neuronal activity, psychostimulants, and disease states
Signaling and Function
Dopamine Reuptake: Primary mechanism for synaptic dopamine clearance (80-90% of released DA)
Termination of Signaling: Rapidly removes dopamine from the synaptic cleft
Neuromodulation: Maintains dopamine tone in basal ganglia circuits
In Vivo: Complex firing patterns influenced by inputs
Ion Channels
L-type calcium channels: Pacemaker current
SK channels: Afterhyperpolarization
Dopamine D2 autoreceptors: Negative feedback
Disease Associations
Parkinson's Disease
DAT neurons in the SNc are selectively vulnerable in PD. [@jankovic2008] Parkinson's disease is characterized by progressive degeneration of dopaminergic neurons. [@kalia2015]
Progressive degeneration: Loss of DAT neurons correlates with disease progression
Lewy bodies: α-Synuclein accumulation in surviving neurons
Biomarker: DAT imaging (SPECT/PET) used for diagnosis
Neuroprotection: DAT as therapeutic target
ADHD
DAT polymorphisms: Several variants associated with ADHD susceptibility
DAT1 10-repeat allele: Linked to increased ADHD risk
Therapeutic: Methylphenidate and amphetamines inhibit DAT
Addiction
Cocaine: Direct DAT inhibitor
Amphetamines: Reverse DAT function (substrate release)
Dysregulation: Chronic use alters DAT expression and function
Schizophrenia
Hypodopaminergic hypothesis: Altered DAT function in prefrontal cortex
Antipsychotics: DAT blockade contributes to some effects
Huntington's Disease
DAT dysfunction: Reduced DAT binding in early HD
Motor symptoms: Nigrostriatal pathway involvement
Therapeutic Relevance
Parkinson's Disease Treatments
Levodopa: Dopamine precursor (converted to dopamine)
DAT inhibitors: Adjunct therapy to extend levodopa effect
Neuroprotection: Targeting DAT to prevent neurodegeneration
Drug Abuse
Cocaine addiction: DAT as primary target
Methamphetamine: DAT-mediated neurotoxicity
Treatment: DAT-blocking medications in development
Imaging Biomarkers
123I-FP-CIT SPECT: DAT binding (DaTscan)
11C-raclopride PET: D2 receptor imaging
Diagnosis: Differentiates PD from essential tremor
Neurodegeneration Mechanisms
α-Synuclein Toxicity
Aggregation: Lewy body formation in DAT neurons
Mitochondrial dysfunction: Complex I deficiency
Autophagy impairment: Lysosomal and proteasomal defects
Excitotoxicity
Glutamate dysregulation: Excessive calcium influx
Metabolic stress: Mitochondrial dysfunction
Oxidative stress: ROS accumulation
Neuroinflammation
Microglial activation: Surrounding DAT neurons
Cytokine release: TNF-α, IL-1β, IL-6
Neurotrophic support: Reduced BDNF signaling
Research Tools
Animal Models
DAT-Cre mice: Genetic targeting of DAT neurons
DAT-KO mice: Knockout of SLC6A3
Conditional KO: Region-specific deletion
α-Synuclein models: PD-like neurodegeneration
Experimental Approaches
Electrophysiology: Patch-clamp recordings
Optogenetics: Channelrhodopsin targeting
Chemogenetics: DREADD manipulation
Calcium imaging: Fiber photometry
Clinical Biomarkers
DAT Imaging
DaTscan (123I-FP-CIT): FDA-approved for PD diagnosis
The study of Dopamine Transporter (Dat) Neurons has evolved significantly over the past decades. [@schultz2002] Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@zigmond1995]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Pathway Diagram
The following diagram shows the key molecular relationships involving Dopamine Transporter (DAT) Neurons discovered through SciDEX knowledge graph analysis: